A big, deep dive into CTA and fractional flow...
Listener feedback on cardiac sarcoidosis, SA ...
Listener feedback on cardiac sarcoidosis, out...
Listener feedback, CRT vs CSP, important clue...
Listener feedback on sports “disqualificati...
The BedMed trial of nighttime BP meds, SURMOU...
The controversial KETO-CTA study, tough decis...
The FDA approval of TAVR for asymptomatic AS,...
AI and ECGs, novel ways to treat hypertension...
The FAME 3 trial 5-year results, TAVR at 5 ye...